Tencent Music

Tencent Music declined 1.8% today, driven primarily by profit-taking after a recent analyst upgrade. Bank of America raised its 12-month target price to $14.31, implying 60% upside, but the market is digesting this new forecast. Pre-market trading climbed to $8.91 before intraday weakness pushed it to $8.755, with a modest post-market rebound to $8.82. The stock has fallen 50.84% year-to-date and trades 67.12% below its September 2025 peak of $26.70, though it has recovered 10.58% from the June 26 low of $7.94. Q1 revenue climbed 12.78% year-over-year to $1.14 billion, but net profit tumbled 48.79% to $302 million. The company recently established a strategic partnership with Chow Tai Fook Life to launch TIMA in Hong Kong this August, with Q2 results due August 11.

Tencent Music (TME) declined 2.51% to $8.94 today, with the decline concentrated during regular trading hours (-1.75% from $9.10 to $8.90), followed by a modest rebound to $8.96 in after-hours trading. The weakness stems from Q1 2026 earnings that showed significant profit pressure despite revenue growth of 12.78% year-over-year to $1.142 billion; earnings per share fell 49.35% to $0.1939 and net profit declined 48.79% to $302.5 million. From a price standpoint, the stock remains down 49.94% year-to-date and trades 66.52% below its 52-week high of $26.70, though it has recovered over 12% from its 52-week low of $7.94 in late June. At a modest PE of 11.0x, valuation looks attractive. TME recently entered a strategic partnership with Chow Tai Fook Life to launch TIMA in Hong Kong, though this new revenue stream has not yet materially supported profitability. The market awaits Q2 2026 earnings on August 11 to see if profit margins stabilize.

TME rose 0.55% to $9.17 today, but this modest recovery masks the stock's 65.66% plunge from its $26.7 peak, primarily driven by Q1 2026's severe profit crisis: while revenue grew 12.78% year-over-year to $1.142 billion, net profit crashed 48.79% to $302.5 million and EPS tumbled 49.35%, signaling severe margin compression. The stock is down 48.66% year-to-date, mirroring the earnings collapse. On the positive, TME partnered with Chow Tai Fook Life to launch TIMA in Hong Kong and underwent management restructuring, signaling repositioning efforts. However, with a PE of 11.3 and $14.2 billion market cap, investors remain cautious on earnings recovery; quantitative signals continue pointing to downside risk, constraining upside momentum.

TME came under modest selling pressure on July 17, dipping to $9.075 during regular trading before closing near $9.120 and recovering to $9.140 in after-hours, as investors grappled with Q1 2026 earnings that showed earnings per share plunging 49.35% year-over-year to $0.1939, despite revenue growth of 12.78% to $1.14 billion. The 48.79% decline in net profit signals mounting cost pressures or intensifying competitive headwinds despite topline expansion. The stock remains severely depressed year-to-date, down 48.94% from $17.86, trading 65.84% below its 52-week high of $26.70 established in September 2025, underscoring a prolonged downtrend. On a more constructive note, TME has forged strategic partnerships, including collaborations with financial institutions to launch the TIMA insurance product expected to debut in Hong Kong in August, while the company is poised to report Q2 2026 results on August 11. At $9.12, the stock trades at a lean forward P/E of 11.24x, above both its 20-day and 60-day moving averages, though Q2 earnings will be critical in determining whether profit headwinds stabilize.

TME rose 4.3% to $9.24 today, climbing intraday to $9.545 before encountering profit-taking pressure in afternoon trading—a pattern reflective of bounce-backs after extended declines. The rebound finds support from two catalysts: the announced long-term strategic partnership with Chow Tai Fook Life and the approaching Q2 2026 earnings report scheduled for August 11. Yet underlying fundamentals remain challenged. Q1 2026 shows operating revenue growth of 12.78% year-over-year to $1.142 billion, but earnings per share of $0.1939 suffered a sharp 49.35% decline alongside a 48.79% drop in net profit to $302 million, signaling pronounced margin compression despite top-line expansion. Operating income of $347 million improved 16.49% sequentially, though profitability momentum appears fragile. Contextually, TME has declined 48.26% year-to-date and trades 65.39% below its 52-week high of $26.70, while holding above both its 20-day moving average of $8.621 and 60-day average of $8.989. Persistent bearish quant signals suggest market skepticism about the earnings trajectory remains entrenched.